The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

As it prepares to launch up to three new products from 2027 through 2028, Moderna is adjusting its way of doing business. The company has hired Ester Banque as its chief commercial officer and has ...

The Moderna Innovation and Technology Centre (MITC) at Harwell Science and Innovation Campus. Moderna and the University of Oxford in the UK have been cleared to start human trials of what could be ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Moderna (MRNA) on Tuesday said that Ester Banque, a former senior executive at Zoetis (ZTS) and Bristol Myers (BMY), will join the company as chief commercial officer as part of organizational changes ...

FDA's advisory committee will vote on June 18 whether mFlusiva benefits outweigh risks in older adults Moderna seeks accelerated approval of mFlusiva for adults 65 and older If approved, mFlusiva will ...

Moderna (MRNA) shares reached the highest level since March after the FDA issued comments that Jefferies said gave a “balanced” view on the company’s flu vaccine candidate, mRNA-1010, ahead of an ...

June 16 (Reuters) - Staff of the U.S. Food and Drug Administration said on Tuesday that data demonstrating a strong immune ‌response to Moderna's flu shot may support effectiveness in adults 65 years ...

Experts from VRBPAC are tasked with voting on two questions Thursday, focused on the risk-benefit profile of mFlusiva for influenza prevention in adults between the ages of 50 and 64 years, as well as ...

Moderna is restructuring its organization and leadership in preparation for a new wave of product launches, expanding President Stephen Hoge's role and appointing longtime pharma executive Ester ...

June 16 (Reuters) - Moderna appointed a new chief commercial officer and widened its president's role to oversee certain franchises, the vaccine maker said on Tuesday, as it prepares for potential ...

S&P 500 ends lower; chips tumble and Moderna rallies The S&P 500 ended marginally lower on Friday, with a steep drop in AI-related chip stocks and sharp gains in Moderna and other healthcare stocks.